Conference
weekly administration of bone-targeted agents (denosumab, zoledronate, or pamidronate) in patients with bone metastases from either breast or castration resistant prostate cancer.
Authors
Clemons MJ; Ong M; Stober C; Ernst DS; Booth CM; Canil CM; Mates M; Robinson AG; Blanchette PS; Joy AA
Volume
37
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
May 20, 2019
Name of conference
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Conference place
Chicago, IL
Conference start date
May 31, 2019
Conference end date
June 4, 2019
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
15
ISSN
0732-183X